cancer-treatment

Documents about cancer-treatment

• Cost-effectiveness analysis of trastuzumab deruxtecan versus ramucirumab plus paclitaxel as second-line treatment for HER2-positive metastatic gastric cancer or gastroesophageal junction adenocarcinoma.#358567NCBI PubMed Central
• Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC#398304ClinicalTrials.gov
• Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial#432891ClinicalTrials.gov
• A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive#467584ClinicalTrials.gov
• 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer#628533ClinicalTrials.gov
• Bevacizumab and Lomustine for Recurrent GBM#810368ClinicalTrials.gov
• Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE#810478ClinicalTrials.gov
• A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer#800552ClinicalTrials.gov
• A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)#800605ClinicalTrials.gov
• A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)#807577ClinicalTrials.gov
• Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer#349958ClinicalTrials.gov
• Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer#429744ClinicalTrials.gov
• A multi-site feasibility study of a stepped-care telehealth intervention for depression and anxiety in post-treatment cancer survivors at community cancer clinics (WF-30917CD)#156460Springer Nature OA
• A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort study#157620HAL (France)
• Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy#806001ClinicalTrials.gov
• Chinese Herbal Medicine Is Associated With Improved Survival in Patients With Advanced Lung Cancer Receiving Standard Treatment: A Nationwide Population-Based Propensity Score Matching Study.#15131NCBI PubMed Central
• Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection#123493ClinicalTrials.gov
• Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)#261506ClinicalTrials.gov
• Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier#312097HAL (France)
• FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study#326131HAL (France)
• Characterization and functional analysis of miRNAs in <i>Salvia miltiorrhiza</i>-isolated exosome-like nanoparticles for gastric cancer treatment#376008PLOS
• The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients: A study of the Rare Cancer Network#402005DataCite
• Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess#466374Spiral
• Knockdown of death receptor 5 antisense long noncoding RNA and cisplatin treatment modulate similar macromolecular and metabolic changes in HeLa cells#650015İzmir Yüksek Teknoloji Enstitüsü
• The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of age#652989IRIS
• 3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors#800351ClinicalTrials.gov
• Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer#800375ClinicalTrials.gov
• Study of Myocardial Function by Speckle Tracking After Cancer Treatment With Anthracyclines in Childhood#810918ClinicalTrials.gov
• Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy#332763ClinicalTrials.gov
• Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human disease#4654Europe PMC
• Analysis and optimal control, with constraints on the state, of a treatment model of tumor invasion by chemotherapy#142467HAL (France)
• Existential distress in advanced cancer: study protocol of a pragmatic randomized controlled trial of a short-term psychodynamic therapy (ORPHYS) compared to usual psycho-oncological treatment (TAU).#161773NCBI PubMed Central
• In Silico Screening of Natural Compounds as Novel Drug Targets for the Treatment of Multiple Myeloma#200316DigitalCommons@USU
• Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma#252978ClinicalTrials.gov
• Identification of potential key genes that respond to capsaicin treatment in ER-positive breast cancer: An integrated analysis#255569PLOS
• Exercise and fasting as adjuvant therapies in the treatment of patients with early-stage breast cancer#277534Research Online
• Vascular Disruption Therapy as a New Strategy for Cancer Treatment#291403Gestión del Repositorio Documental de la Universidad de Salamanca
• Lipid-based nanocarriers as transformative treatment in tuberculosis: a systematic review of therapeutic efficacy#320102Figshare
• Supporting data for "Pt1a and tyrosine kinase inhibitor combination treatment exerts synergistic anti-hepatocellular carcinoma effect through RNA m6A methylation modification".#344096Figshare
• BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma#349952ClinicalTrials.gov
• Noninvasive treatment strategy for abdominal wall desmoid tumors applying high-intensity focused ultrasound#433210Figshare
• The Use of Oncology Electronic Health Record Databases to Assess the Effectiveness of Breast Cancer Treatment#643545Harvard DASH
• Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial#677111HAL (France)
• A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC#800330ClinicalTrials.gov
• Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia#802578ClinicalTrials.gov
• Omega 3 FA Supplements as Augmentation in the Treatment of Depression#804179ClinicalTrials.gov
• Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort#274682IRIS
• Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017#338807OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study#125838ClinicalTrials.gov
• High-Dose-Rate Brachytherapy for Treatment of Facial Skin Cancers: Local Control, Toxicity, and Quality of Life in 67 Patients#137361HAL (France)